Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
cerdulatinib (ALXN2075)
i
Other names:
ALXN2075, RVT-502, PRT062070, PRT 2070, PRT-062070
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(2)
News
Trials
Company:
AstraZeneca, Nicox
Drug class:
SYK inhibitor, JAK inhibitor
Related drugs:
‹
GS-9973 (20)
CB-659 (4)
fostamatinib (2)
GS-9876 (2)
HM43239 (2)
BAY-61-3606 (1)
EC-70124 (1)
NMS-0963 (0)
PRT062607 (0)
piceatannol (0)
HMPL-523 (0)
Max-40279 (2)
tofacitinib XR (1)
AT9283 (0)
TQ05105 (0)
GS-9973 (20)
CB-659 (4)
fostamatinib (2)
GS-9876 (2)
HM43239 (2)
BAY-61-3606 (1)
EC-70124 (1)
NMS-0963 (0)
PRT062607 (0)
piceatannol (0)
HMPL-523 (0)
Max-40279 (2)
tofacitinib XR (1)
AT9283 (0)
TQ05105 (0)
›
Associations
(2)
News
Trials
VERI cancer hierarchy
Reset Filters
MYB-TYK2 fusion
B Acute Lymphoblastic Leukemia
MYB-TYK2 fusion
B Acute Lymphoblastic Leukemia
ALXN2075
Sensitive: D – Preclinical
ALXN2075
Sensitive
:
D
ALXN2075
Sensitive: D – Preclinical
ALXN2075
Sensitive
:
D
MYB-TYK2 fusion
B Acute Lymphoblastic Leukemia
MYB-TYK2 fusion
B Acute Lymphoblastic Leukemia
vorinostat + ALXN2075
Sensitive: D – Preclinical
vorinostat + ALXN2075
Sensitive
:
D
vorinostat + ALXN2075
Sensitive: D – Preclinical
vorinostat + ALXN2075
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login